Events

Brokerage Event NCP UK/KTN - Horizon Europe Consortia Building Event - Cluster 1 Health
JUN
Mon
14
09:00 - 17:00

This was 4 years ago

Location

Online

Programmes
Health

The UK National Contract Points (NCPs) in collaboration with the KTN Global Alliance are organising a Horizon Europe consortia building event on the Horizon Europe Health Cluster for potential applicants (in the UK, Europe and beyond).

This event focusses on those who have identified specific 2021 call topics or at least areas of interest in the draft Health Work Programme, and are ready to take the next steps, discussing concrete project ideas with potential partners and going forward to a proposal submission.

More detailed information about this online event and registration can be found here

 

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.